Saluda Medical

Bloomington, United States Founded: 2010 • Age: 16 yrs Listed
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment

About Saluda Medical

Saluda Medical is a publicly listed company based in Bloomington (United States) founded in 2010. Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment. Saluda Medical has raised $530 million across 9 funding rounds from investors including Fidelity Investments, Medtronic and Boston Scientific. Its chief executive, as recorded, is Jim Schuermann. Saluda Medical offers products and services including Evoke System and SmartLoop Technology. Its focus areas include Life Sciences, Pain Management, Medical Devices and Therapeutic Devices. Its legal entity is SALUDA MEDICAL EUROPE LIMITED. Its competitors include Myoscience, Nalu Medical and Neuros Medical; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 2010 and headquartered in Bloomington, United States, Saluda Medical operates in the neuromodulation sector. A system is provided that measures and records neural activation characteristics for treating chronic neurological conditions, particularly pain. Stimulation levels are quantified against clinician-defined targets, with continuous comparisons and automatic adjustments to maintain consistent activation. Evoked Compound Action Potentials are utilized to enhance therapy precision.

Key Metrics
  • Annual Revenue
    $91.65 M (USD)
    22.5
    as on Jun 30, 2026
  • Net Profit
    -$152.02 M (USD)
    4.26
    as on Jun 30, 2026
  • EBITDA
    -$148.47 M (USD)
    -19.94
    as on Jun 30, 2026
  • Total Equity Funding
    $530M (USD)

    in 9 rounds

  • Latest Funding Round
    $30M (USD), Series B

    Oct 2025

  • Investors

Products & Services of Saluda Medical

Saluda Medical offers a comprehensive portfolio of products and services, including Evoke System and SmartLoop Technology.

Evoke System
Neuromodulation Device

Device for closed-loop spinal cord stimulation to treat chronic pain.

SmartLoop Technology
Stimulation Technology

Technology that adjusts neural stimulation based on patient responses.

Apps and channels of Saluda Medical

its YouTube channel Saluda Medical has 695 subscribers and 23 videos.

Saluda Medical
YouTube 695 subscribers 23 videos Science & Technology
Open channel

Videos from Saluda Medical

The most watched videos on Saluda Medical's YouTube channel, Saluda Medical (695 subscribers). Click a video to play it here.

How Spinal Cord Stimulation (SCS) Works
11.8K views
Pam L. Evoke® SmartSCS™ System Patient
8.6K views
How Closed-Loop SCS Works (Part 1)
7.7K views
Evoke System Guide: Remote Control (U.S.)
7.6K views

More on Saluda Medical.

Funding Insights of Saluda Medical

Saluda Medical has successfully raised a total of $530M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $530M
  • Total Rounds 9
  • Last Round Series B — $30M
  • First Round $10M

    (Feb 2012)

  • Investors Count 11

All 9 funding rounds of Saluda Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2025$30MSeries B––
–
Jan 2025$100MSeries F–Redmile Group
Apr 2023$150MSeries F–Wellington
Mar 2022$125MSeries F–Redmile Group
Jun 2019$75MSeries E–Boston Scientific, Redmile Group
–
Jun 2019Debt – Conventional––
May 2017$40MSeries D–Action Potential Venture Capital
Jul 2013$5MGrant––
Feb 2012$10MSeries B–BioScience Managers
–
Valuation history

11 investors in total: 11 institutional.

Investors in Saluda Medical

Saluda Medical has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Medtronic and Boston Scientific.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Fund of funds focused on pre-seed and seed-stage companies
1992tpg.comFort Worth, United States
Stage-agnostic investments in US life sciences are pursued.
actionpotentialvc.comPalo Alto, United States
BioScience Managers is engaged in healthcare investment and innovation.
biosciencemanagers.comMelbourne, Australia
Operates as an employee-owned hedge fund focused on long/short equity strategies.
2007redmilegroup.comSan Francisco, United States
Diversified investment management services are provided to institutional clients.
wellington.comBoston, United States
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms
1946fidelity.comBoston, United States
Diversified asset management services are provided to investors globally.
1937troweprice.comBaltimore, United States
Wide range of medical devices
1979bostonscientific.comMarlborough, United States
Medical equipment for treating over 30 chronic diseases is developed.
1949medtronic.comMinneapolis, United States
NSW Health is tasked with providing public health services across New South Wales.
health.nsw.gov.auSt Leonards, Australia
Premium access

Investor details for Saluda Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Saluda Medical

145 people are tracked at Saluda Medical (27 in leadership, 118 in team).

NameRoleGroup
Jim Schuermann
CEOLeadership
Dean Karantonis
VP of Therapy DevelopmentLeadership
Kyle Schreiner
Senior Regional DirectorLeadership
Dave Mugan
VP & Head of EU OperationsLeadership
Brandon Governale
Regional DirectorLeadership
Loren Buchanan
Director, Global Commercial MarketingLeadership
Sadie Mauser
Director Of QualityLeadership
Nicole Soliday
Head Of Clinical EvidenceLeadership
Danielle Fried
Senior Regional Sales DirectorLeadership
Tim Johnson
West Vice PresidentLeadership
Andrew Hancock
Director Of ManufacturingLeadership
Ryan Bohlen
Associate Director - Supply ChainLeadership
Holger Krauss
Area Director DACHLeadership
Kappy Pauna
Sr. Director, Human ResourcesLeadership
Nancy O'Connell
Director Global Clinical OperationsLeadership
Rac Erika Huffman
Regulatory Project DirectorLeadership
Bekezela Ngwenya
Director, Operations QualityLeadership
Daniela Mlynek
Senior Clinical Specialist & Clinical Excellence Partner GermanyLeadership
Georgina Clare
Vice President Human ResourcesLeadership
Quynh Stella
Sr. Director, Product ManagementLeadership

125 more people are available in the full profile.

Premium access

Complete people profiles for Saluda Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Saluda Medical

Saluda Medical is a publicly listed company on the ASX with ticker symbol SLD in Australia. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date05 Dec 2025
  • Listed onASX: SLD
  • Listed entitySaluda Medical Inc
  • ISINAU0000432114
  • Share price0.39 AUD (-2.53% on the day) · 2026-10-14
  • Market capitalisation104,589,881.15 AUD
  • EPS (diluted, trailing year)-0.87 AUD
  • Volume (last session)235,093

Financials of Saluda Medical

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2026133.1M AUD-220.7M AUD-215.6M AUD
2025108.6M AUD-230.5M AUD-179.7M AUD
202478.9M AUD-149.3M AUD-148.4M AUD
202333.0M AUD-137.0M AUD-135.2M AUD
Premium access

Detailed financial statements for Saluda Medical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Saluda Medical

4 dated milestones of Saluda Medical across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Saluda Medical is founded.
  2. Funding First funding round of $10.0M.
  3. Funding Latest funding round, Series B, of $30.0M.
  4. IPO Lists on the stock exchange (IPO).

Competitors of Saluda Medical

Saluda Medical has 3 listed competitors in our database, 3 of them funded. They include Myoscience, Nalu Medical and Neuros Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
myoscience.com2005Redwood, United States$147.68M687
Technology-driven dermatological products are developed and commercialized.
nalumed.com2014Carlsbad, United States$230.97M
Developer of a neurostimulation system for managing intractable chronic pain
neurosmedical.com2008Cleveland, United States$145.2M28
High-frequency neurostimulation therapies for chronic neuropathic pain are developed.
Premium access

Detailed competitors of Saluda Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Saluda Medical

The website of Saluda Medical (saludamedical.com) receives about 8.5K visits a month.

  • Monthly visits
    8.5K

    ▼ 56% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Saluda Medical (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Saluda Medical

Premium access

Complete news archive for Saluda Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saluda Medical

Saluda Medical was founded in 2010 and raised its 1st funding round 2 years after it was founded.

Saluda Medical is headquartered in Bloomington, United States. It is registered at Bloomington, Indiana, United States.

Jim Schuermann is the CEO of Saluda Medical, as recorded in our data.

Saluda Medical is a funded company, having raised a total of $530M across 9 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Feb 2012.

Annual revenue of Saluda Medical is $91.65M as on Jun 30, 2026.

Founded in 2010 and headquartered in Bloomington, United States, Saluda Medical operates in the neuromodulation sector. A system is provided that measures and records neural activation characteristics for treating chronic neurological conditions, particularly pain. Stimulation levels are quantified against clinician-defined targets, with continuous comparisons and automatic adjustments to maintain consistent activation. Evoked Compound Action Potentials are utilized to enhance therapy precision.

Saluda Medical's top competitors include Nalu Medical, Myoscience and Neuros Medical.

Saluda Medical offers Evoke System and SmartLoop Technology.

Yes, Saluda Medical is publicly traded on ASX under the ticker symbol SLD.

Saluda Medical has 11 investors. Key investors include Fidelity Investments, Medtronic, Boston Scientific, TPG, and T. Rowe Price.

Saluda Medical operates through Saluda Medical Europe Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available